Inhibitor-enzyme

Enzyme inhibitors are chemicals that may serve as a natural means of controlling metabolic activity by reducing the number of enzyme molecules available for catalysis. In many cases, natural or synthetic inhibitors have allowed us to unravel the pathways and mechanisms of intermediary metabolism. Enzyme inhibitors may also be used as pesticides or drugs. Such materials are designed so that they inhibit a specific enzyme that is peculiar to an organism or a disease state. For example, a good antibiotic may inhibit a bacterial enzyme, but it should have no effect on the host person or animal. 

We may consider enzyme inhibitors as either irreversible or reversible inhibitors. Some inhibitors become covalently linked to the enzyme and are bound so strongly that they cannot be removed. As a result, the enzyme activity decreases and eventually becomes zero. 

Irreversible inhibition in an organism usually results in a toxic effect. Examples of this type of inhibitor are the organophosphorus compounds that interfere with acetylcholinesterase (see Box 7.26). The organophosphorus derivative reacts with the enzyme in the normal way, but the phosphory-lated intermediate produced is resistant to normal hydrolysis and is not released from the enzyme. 

The enzyme becomes inactivated, and a toxic level of acetylcholine builds up. Organophosphorus compounds provide a range of insecticides and nerve gases. 

Reversible inhibitors are potentially less damaging. In the presence of a reversible inhibitor, the enzyme activity decreases, but to a constant level as equilibrium is reached. The enzyme activity reflects the lower level of enzyme available for catalysis. We can subdivide the reversible inhibition into three types, i.e. competitive, non-competitive, and allosteric inhibition. 

Enzyme inhibitors are species that cause a decrease in the activity of an enzyme. Inhibitors usually interact with the enzyme itself, forming enzyme-inhibitor (E I) complexes, but in a few cases, the inhibition mechanism involves reaction with one of the substrates. Inhibition is considered to be reversible if the enzyme recovers its activity when the inhibitor is removed, and irreversible if the inhibitor causes a permanent loss of activity. Reversible inhibition affects the specific activity and apparent Michaelis-Menten parameters for the enzyme, while irreversible inhibition (where the E I complex formation is irreversible) simply decreases the concentration of active enzyme present in the sample. A well-known example of irreversible inhibition is the effect of nerve gas on the enzyme cholinesterase. 

The curvature seen for reversible inhibition [Fig. 2.12 (a)] indicates that an inhibitor-binding equilibrium precedes the conversion of substrate to product. Three types of reversible inhibition may be distinguished. (1) Competitive inhibition occurs when the degree of inhibition decreases as substrate concentration increases and Vmax is unaffected. (2) Noncompetitive inhibition exists when the degree of inhibition does not vary with substrate concentration, and Km is unaffected. (3) Uncompetitive inhibition exists if the degree of inhibition increases as substrate concentration increases both Vmax and Km are affected. Uncompetitive inhibition is often thought of as a mixture of competitive and noncompetitive behavior. 

The toxicant may react with an enzyme or a transport protein and inhibit its normal function. Enzymes may be inhibited by a compound that has a similar, but not identical structure as the true substrate instead of being processed, it blocks the enzyme. Typical toxicants of this kind are the carbamates and the organophosphorus insecticides that inhibit the enzyme acetyl cholinesterase. Some extremely efficient herbicides that inhibit enzymes important for amino acid synthesis in plants, e.g., glyphosate and glufosinate, are other good examples in this category. 

Enzyme inhibitors may or may not be very selective, and their effects depend on the importance of the enzyme in different organisms. Plants lack a nervous system and acetylcholinesterase does not play an important role in other processes, whereas essential amino acids are not produced in animals. Glyphosate and other inhibitors of amino acid synthesis are therefore much less toxic in animals than in plants, and the opposite is true for the organophosphorus and carbamate insecticides. 

Sulfhydryl groups are often found in the active site of enzymes. Substances such as the Hg++ ion have a very strong affinity to sulfur and will therefore inhibit most enzymes with such groups, although the mercury ion does not resemble the substrate. In this case, the selectivity is low. 

It has been noted that certain substances slow down and even stop enzyme-controlled reactions they are called inhibitors. Competitive inhibition occurs when a molecule has a similar molecular configuration to the substrate it therefore competes with the normal substrate for the active site and may slow down the reaction. The degree of inhibition depends on the relative concentrations of the substrate and inhibitor. Non-competitive inhibition occurs when the inhibitor attaches itself permanently to the active site the extent of inhibition depends entirely on the inhibitor concentration and cannot be altered by changing the amount of substrate present. Arsenic and heavy metals such as mercury and silver are toxic because they are inhibitors (non-competitive). Nerve gas, developed during the Second World War, is another example of an inhibitor it combines competitively with the enzyme cholinesterase and slows down the transmission of nerve impulses from one cell to another. 

Enzyme inhibitors are not always bad news moment-to-moment variations in the rate of cellular metabolism are caused by the control of enzyme action by inhibtors that occur naturally in the body. 

Catalysts A and B both catalyse the decomposition of hydrogen peroxide to give oxygen gas. The data in Table 5.3.3 were obtained when the two catalysts were used. 

If you score less than 807o. then work through the text and re-test yourself at the end by using this same test. If you still have a low score then re-work the unit at a later date. 

Two chemicals will only react if the particles collide and have sufficient kinetic energy to overcome the energy barrier (activation energy). 

Another class of therapeutic agents is used for the treatment of certain genetic diseases or other enzymatic disorders caused by the dysfunction or absence of one particular enzyme. This often leads to an unwanted accumulation or imbalance of metaboUtes in the organism. Eor example, some anticonvulsive agents are inhibitors for y-aminobutyric acid aminotransferase [9037-67-6]. An imbalance of two neurotransmitters, glutamate and y-aminobutyric acid, is responsible for the symptoms. Inhibition of the enzyme leads to an increase of its substrate y-aminobutyric acid, decreasing the imbalance and subsequently relieving the symptoms of the disease. 

An important dmg in the regulation of cholesterol metaboHsm is lovastatin [75330-75-5] which is an HMG—CoA reductase inhibitor (see Cardiovascularagents). p-Hydroxy-p-methyl glutarate—coenzyme A (HMG—CoA) reductase is the rate-limiting enzyme of cholesterol synthesis. Lovastatin is actually a prodmg, which is eventually hydrolyzed in the Hver to its active, P-hydroxylated form (5). 

The enzyme inhibitors discussed in this article may be classified as follows  

Kirk-Othmer Encyclopedia of Chemical Technology (4th Edition) 

A competitive inhibitor biads to the same enzyme form as the substrate, competing for the same site, such that the inhibitor and substrate prevent one another from binding. This may be represented as follows -Compet twe inhibition 

---

Application of the CCM to small sets (n < 6) of enzyme inhibitors revealed correlations between the inhibitory activity and the chirality measure of the inhibitors, calculated by Eq. (26) for the entire structure or for the substructure that interacts with the enzyme (pharmacophore) [41], This was done for arylammonium inhibitors of trypsin, Di-dopamine receptor inhibitors, and organophosphate inhibitors of trypsin, acetylcholine esterase, and butyrylcholine esterase. Because the CCM values are equal for opposite enantiomers, the method had to be applied separately to the two families of enantiomers (R- and S-enantiomers). 

Bartlett P A and C K Marlowe 1987. Evaluation of Intrinsic Binding Energy from a Hydrogen-bondi Group in an Enzyme Inhibitor. Science 235 569-571. 

J1992. LUDI - Rule-Based Automatic Design of New Substituents for Enzyme Inhibitor Leads. mal of Computer-Aided Molecular Design 6 593-606. 

Kubinyi H1998. Structure-based Design of Enzyme Inhibitors and Receptor Ligands. Current Opinion i. Drug Discovery and Development 1 5-15. 

In the case of competitive inhibition, the equilibrium between the enzyme, E, the inhibitor, 1, and the enzyme-inhibitor complex, El, is described by the equilibrium constant Ki. 

Enzyme catalysis Enzyme electrode Enzyme immobilization Enzyme immunoassay Enzyme inhibitors... 

ALCOHOLS,HIGHERALIPHATIC - SYNTTiETIC PROCESSES] (Vol 1) -enzyme inhibitors as [ENZYME INHIBITORS] (Vol 9)... 

Quantitative Structure—Activity Relationships (QSAR). Quantitative Stmcture—Activity Relationships (QSAR) is the name given to a broad spectmm of modeling methods which attempt to relate the biological activities of molecules to specific stmctural features, and do so in a quantitative manner (see Enzyme INHIBITORS). The method has been extensively appHed. The concepts involved in QSAR studies and a brief overview of the methodology and appHcations are given here. 

The esters of monofluorophosphoric acid are of great interest because of their cholinesterase inhibiting activity which causes them to be highly toxic nerve gases and also gives them medical activity (see Enzyme inhibitors). The most studied is the bis(l-methylethyl)ester of phosphorofluoridic acid also known as diisopropyl phosphorofluoridate [155-91 DFP (5), and as the ophthalmic ointment or solution Isoflurophate USP. It is used as a... 

He/minthosporium (15). The mode of action is considered to be inhibition of the enzyme NADPH-cytochrome C reductase, which results in the generation of free radicals and/or peroxide derivatives of flavin which oxidize adjacent unsaturated fatty acids to dismpt membrane integrity (16) (see Enzyme inhibitors). 

One approach to combating antibiotic resistance caused by P-lactamase is to inhibit the enzyme (see Enzyme inhibition). Effective combinations of enzyme inhibitors with P-lactam antibiotics such as penicillins or cephalosporins, result in a synergistic response, lowering the minimal inhibitory concentration (MIC) by a factor of four or more for each component. However, inhibition of P-lactamases alone is not sufficient. Pharmacokinetics, stability, ability to penetrate bacteria, cost, and other factors are also important in determining whether an inhibitor is suitable for therapeutic use. Almost any class of P-lactam is capable of producing P-lactamase inhibitors. Several reviews have been pubUshed on P-lactamase inhibitors, detection, and properties (8—15). 

The proposed pathway for the biosynthesis of the avermectins (Fig. 3) has been described in a review (23). Some of the details are yet to be elucidated, although the steps, in general, are based on firm evidence from four types of studies incorporation of labeled precursors, conversion of putative intermediates by producing strains and blocked mutants, in vitro measurement of biosynthetic enzymes, and studies with enzyme inhibitors. The biosynthesis of the oleandrose units was elucidated from studies using and labeled glucose, which indicated a direct conversion of glucose to... 

Enzyme appHcations in organic synthesis Enzyme, inhibitors... 

---